Other languages Genscript Biotech Corporation

Equities

1548

KYG3825B1059

Market Closed - Hong Kong S.E. Other stock markets 04:08:22 2024-04-29 am EDT			5-day change	1st Jan Change
11.76 ^HKD	+6.72%		+6.72%	-40.79%

Apr. 23	Multiply Labs and GenScript Biotech Corporation Collaborate to Automate Cell Isolation and Enrichment Phase of Cell Therapy Manufacturing	CI
Apr. 23	Genscript Biotech Unit Gets Approval for Blood Cancer Drug by European Commission	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Multiply Labs and GenScript Biotech Corporation Collaborate to Automate Cell Isolation and Enrichment Phase of Cell Therapy Manufacturing	Apr. 23
Genscript Biotech Corporation Announces Directorate Appointments and Change in Composition of Board Committee	Apr. 12
Genscript Biotech Unit's Refractory Multiple Myeloma Drug Gets FDA Approval	Apr. 08
Genscript Biotech's US Unit Secures FDA Nod for Anti-Cancer Medication	Mar. 19
Genscript Biotech Issues 444,598 Shares to Three Grantees Under Restricted Share Scheme	Mar. 14
Genscript Biotech's 2023 Loss Widens; Misses Revenue Estimates	Mar. 10
Genscript Biotech Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 10
Genscript Announces Appointment of Dr. David R. Liu to the Scientific Advisory Board	Mar. 08
GenScript Biotech Corporation Expands Collaboration with Roche	Mar. 05
Genscript Biotech Unit Rakes in $159 Million in Sales for Myeloma Treatment; Shares Rise 4%	Jan. 24
Genscript Biotech Unit to Submit More Data to European, US Authorities for Approval of Myeloma Drug	Jan. 24
Genscript, Legend Biotech On-Track to Begin Production at Ghent Facilities This Year	Jan. 10
Genscript Biotech's Subsidiary Legend Closes License Agreement with Novartis for Anti-Cancer Drug	Jan. 04
Genscript Biotech Unit Secures US FDA Nod for Carvykti Label Update	Dec. 21
Genscript Biotech's Controlling Shareholder Sells 0.4% Stake to Hillhouse Unit	Dec. 20
Genscript Biotech Controlling Shareholder Disposes of 8.6 Million Shares	Dec. 12
Genscript Biotech's US Subsidiary Presents Positive Results of Carvykti Drug from Phase 3 Study	Dec. 12
Genscript Subsidiary Legend Biotech Grants Novartis License to Develop Anti-Cancer Drug	Nov. 13
Genscript Biotech's Carvykti Rakes in $152 Million in Q3 Net Trade Sales; Shares Fall 5%	23-10-17
Hong Kong Stocks Gain on China's Better-Than-Expected Industrial Data; China Evergrande Slumps 19%	23-09-27

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Genscript Biotech Corporation

Equities

1548

KYG3825B1059

Other languages

Filters